J
Jean-Pierre Cambou
Researcher at French Institute of Health and Medical Research
Publications - 149
Citations - 7470
Jean-Pierre Cambou is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Myocardial infarction & Population. The author has an hindex of 37, co-authored 149 publications receiving 7297 citations.
Papers
More filters
Journal ArticleDOI
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.
François Cambien,Odette Poirier,Laure Lecerf,Alun Evans,Jean-Pierre Cambou,Dominique Arveiler,Gérald Luc,Jean-Marie Bard,L Bara,Sylvain Ricard +9 more
TL;DR: It is reported that the DD genotype, which is associated with higher levels of circulating ACE than the ID and II genotypes, is significantly more frequent in patients with myocardial infarction than in controls, especially among subjects with low body-mass index and low plasma levels of ApoB.
Journal ArticleDOI
Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction.
Etienne Puymirat,Tabassome Simon,Philippe Gabriel Steg,Francois Schiele,Pascal Gueret,Didier Blanchard,Khalife Khalife,Patrick Goldstein,Simon Cattan,Laurent Vaur,Jean-Pierre Cambou,Jean Ferrières,Nicolas Danchin,Fast Mi Investigators +13 more
TL;DR: In France, the overall rate of cardiovascular mortality among patients withSTEMI decreased from 1995 to 2010, accompanied by an increase in the proportion of women younger than 60 years with STEMI, changes in other population characteristics, and greater use of reperfusion therapy and recommended medications.
Journal ArticleDOI
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
Nicolas Danchin,Pierre Coste,Jean Ferrières,Philippe-Gabriel Steg,Yves Cottin,Didier Blanchard,Loic Belle,Bernard Ritz,Gilbert Kirkorian,Michael Angioi,Philippe Sans,Bernard Charbonnier,Hélène Eltchaninoff,Pascal Gueret,Khalife Khalife,Philippe Asseman,Jacques Puel,Patrick Goldstein,Jean-Pierre Cambou,Tabassome Simon +19 more
TL;DR: When used early after the onset of symptoms, a pharmacoinvasive strategy that combines thrombolysis with a liberal use of PCI yields early and 1-year survival rates that are comparable to those of PPCI.
Journal ArticleDOI
β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction The ECTIM Study
Isabelle Behague,Odette Poirier,Viviane Nicaud,Alun Evans,Dominique Arveiler,Gérald Luc,Jean-Pierre Cambou,Pierre-Yves Scarabin,Lucienne Bara,Fiona Green,François Cambien +10 more
TL;DR: In this paper, the results of a detailed analysis of the β fibrinogen gene in relation to plasma fibrINogen and to the severity of coronary artery disease (CAD) in patients with myocardial infarction (MI) in the ECTIM Study were presented.
Journal ArticleDOI
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.
F. Cambien,O Costerousse,Laurence Tiret,Odette Poirier,Laure Lecerf,Marie-Françoise Gonzales,A. E. Evans,D. Arveiler,Jean-Pierre Cambou,G. Luc +9 more
TL;DR: It is indicated that plasma ACE level may be a risk factor for MI, independent of the ACE I/D polymorphism, as measured from frozen aliquots of plasma in a large subsample of the ECTIM study.